Physician profile
Robert Bernard Kaufman
NPI 1003885856
$1,254.11
in general payments reported to CMS, 2019-2025
12 companies · $96.85 in 2025
The $96.85 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $248 · 2022: $171 · 2023: $187 · 2024: $126 · 2025: $96.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.86 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $368.92 | 2019-2025 | Rocklatan, Clareon Panoptix Pro |
| Abbvie INC. | $241.98 | 2022-2024 | |
| Novo Nordisk INC | $196.64 | 2019-2020 | |
| Shire North American Group INC | $122.76 | 2019 | |
| Mallinckrodt Hospital Products INC. | $117.77 | 2020 | |
| Rxsight INC | $81.58 | 2022 | |
| Allergan, INC. | $25.27 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $23.67 | 2019 | |
| Oyster Point Pharma, INC. | $23.13 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
| Sight Sciences, INC. | $16.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.